{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:15:30Z","timestamp":1783430130886,"version":"3.54.6"},"reference-count":9,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,11,6]],"date-time":"2008-11-06T00:00:00Z","timestamp":1225929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Cosmetic Dermatology"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Several chemical agents are currently used to perform superficial peels of the face to reduce facial hyperpigmentation and fine\u00a0lines\/wrinkles. Some of the most commonly used agents are alpha\u00a0hydroxyl\u00a0acids, such as glycolic acid (GA), or beta\u00a0hydroxy\u00a0acid, such as salicylic acid.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> This study aims to compare the efficacy of GA to that of a novel derivative of salicylic acid, capryloyl salicylic acid (LHA).<\/jats:p><jats:p><jats:bold>Subjects\/Methods\u2002<\/jats:bold> In a split\u2010face study, 50 female volunteers between the ages of 35 and 60\u00a0years with mild to moderate facial hyperpigmentation and fine lines\/wrinkles were randomized and LHA or GA peel was applied to one side of the face. Increasing peel concentrations were applied (5\u201310% LHA or 20\u201350% GA) based on the tolerance level of the subjects and clinical observations of an expert dermatologist for 12\u00a0weeks at biweekly intervals.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Of the 44 volunteers who completed the study, at 12\u00a0weeks 41% of LHA\u2010treated and 30% of GA\u2010treated subjects demonstrated significant reduction of fine lines\/wrinkles compared to baseline. Forty\u2010six percent of LHA\u2010treated subjects and 34% of GA\u2010treated subjects showed significant reduction of hyperpigmentation compared to baseline. LHA treatment was better than GA peels, although there were no statistically significant differences between the two groups.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Five percent to 10% of LHA peel is generally safe and as effective as 20\u201350% GA peel in reducing facial hyperpigmentation and fine lines\/wrinkles.<\/jats:p>","DOI":"10.1111\/j.1473-2165.2008.00403.x","type":"journal-article","created":{"date-parts":[[2008,11,6]],"date-time":"2008-11-06T08:19:36Z","timestamp":1225959576000},"page":"259-262","source":"Crossref","is-referenced-by-count":22,"title":["Clinical tolerance and efficacy of capryloyl salicylic acid peel compared to a glycolic acid peel in subjects with fine\u00a0lines\/wrinkles and hyperpigmented skin"],"prefix":"10.1111","volume":"7","author":[{"given":"Christian","family":"Oresajo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Yatskayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Hansenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,11,6]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.1993.tb00343.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(18)30082-2"},{"key":"e_1_2_5_4_2","first-page":"148","article-title":"The therapeutic value of glycolic acid peels in dermatology","volume":"69","author":"Grover C","year":"2003","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.1996.tb00347.x"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.1998.tb04162.x"},{"key":"e_1_2_5_7_2","unstructured":"JacquetB LevequeJL HocquauxM LegerDS inventors; L\u2019Oreal assignee.Topical compositions intended for skin treatment containing salicylic acid. US patent 4\u00a0767\u00a0750. August 30 1988."},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1473-2165.2007.00296.x"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21109"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4725.1999.08145.x"}],"container-title":["Journal of Cosmetic Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1473-2165.2008.00403.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1473-2165.2008.00403.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T22:26:33Z","timestamp":1696976793000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1473-2165.2008.00403.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,6]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["10.1111\/j.1473-2165.2008.00403.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1473-2165.2008.00403.x","archive":["Portico"],"relation":{},"ISSN":["1473-2130","1473-2165"],"issn-type":[{"value":"1473-2130","type":"print"},{"value":"1473-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,6]]}}}